Screener Summaries Updates Institutions Sign In More Updates › Other Events › RGNT Other Events · Jul 9, 2026
On July 9, 2026, Regentis Biomaterials Ltd. announced that shareholders approved all fourteen proposals presented at… RGNT Regentis Biomaterials Ltd.
On July 9, 2026, Regentis Biomaterials Ltd. announced that shareholders approved all fourteen proposals presented at the Adjourned Annual General Meeting of Shareholders. The proposals were previously detailed in the Company’s Notice and Proxy Statement dated May 28, 2026, and its subsequent amendment from June 4, 2026. Regentis Biomaterials Ltd. is a biotechnology company focused on developing biomaterials for medical applications.
More from Regentis Biomaterials Ltd. Regentis Biomaterials reported a net loss of $2.6 million, or $0.44 per share, for the six months ended June 30, 2026… Sep 11, 2026 Regentis Biomaterials Ltd. announced that the Japan Patent Office has issued a Notice of Allowance for its proprietary… Jul 20, 2026 On July 15, 2026, Regentis Biomaterials Ltd. announced it received European regulatory approval for a new GelrinC… Jul 15, 2026 Regentis Biomaterials Ltd. adjourned its Annual General Meeting of Shareholders, originally scheduled for July 2… Jul 2, 2026 Regentis Biomaterials Ltd. entered into definitive securities purchase agreements on June 17, 2026, to issue and sell… Jun 18, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
